Patrick Donnelly

Stock Analyst at Citigroup

(3.88)
# 690
Out of 4,711 analysts
307
Total ratings
54.82%
Success rate
7.75%
Average return

Stocks Rated by Patrick Donnelly

Fortrea Holdings
Dec 11, 2024
Downgrades: Neutral
Price Target: $30$23
Current: $19.26
Upside: +19.42%
Illumina
Dec 11, 2024
Downgrades: Neutral
Price Target: $190$165
Current: $136.02
Upside: +21.31%
Mettler-Toledo International
Dec 11, 2024
Upgrades: Neutral
Price Target: $1,200$1,300
Current: $1,230.74
Upside: +5.63%
QuidelOrtho
Dec 11, 2024
Upgrades: Buy
Price Target: $44$50
Current: $44.84
Upside: +11.51%
Sotera Health Company
Nov 6, 2024
Maintains: Buy
Price Target: $18$20
Current: $13.24
Upside: +51.06%
Bruker
Nov 6, 2024
Maintains: Buy
Price Target: $80$75
Current: $57.00
Upside: +31.58%
Exact Sciences
Nov 6, 2024
Maintains: Buy
Price Target: $80$75
Current: $59.40
Upside: +26.26%
Bio-Rad Laboratories
Oct 31, 2024
Maintains: Buy
Price Target: $400$450
Current: $327.47
Upside: +37.42%
Bio-Rad Laboratories
Oct 31, 2024
Maintains: Buy
Price Target: $400$450
Current: $325.85
Upside: +38.10%
10x Genomics
Oct 30, 2024
Maintains: Buy
Price Target: $35$23
Current: $14.04
Upside: +63.82%
Maintains: Buy
Price Target: $165$185
Current: $153.10
Upside: +20.84%
Downgrades: Neutral
Price Target: $95$85
Current: $71.65
Upside: +18.63%
Downgrades: Sell
Price Target: $215$175
Current: $185.77
Upside: -5.80%
Maintains: Buy
Price Target: $150$165
Current: $134.51
Upside: +22.67%
Maintains: Buy
Price Target: $40$45
Current: $31.67
Upside: +42.09%
Maintains: Buy
Price Target: $30$28
Current: $20.56
Upside: +36.19%
Maintains: Buy
Price Target: $135$145
Current: $112.56
Upside: +28.82%
Downgrades: Neutral
Price Target: $30$23
Current: $21.21
Upside: +8.44%
Downgrades: Neutral
Price Target: $85
Current: $73.17
Upside: +16.17%
Maintains: Buy
Price Target: $280$290
Current: $228.55
Upside: +26.89%
Reinstates: Neutral
Price Target: $620
Current: $524.05
Upside: +18.31%
Maintains: Buy
Price Target: $62$60
Current: $44.67
Upside: +34.32%
Maintains: Neutral
Price Target: $265$300
Current: $368.16
Upside: -18.51%
Maintains: Buy
Price Target: $7$9
Current: $3.64
Upside: +147.25%
Maintains: Neutral
Price Target: $190$225
Current: $197.27
Upside: +14.06%
Maintains: Buy
Price Target: $300$315
Current: $207.51
Upside: +51.80%
Maintains: Neutral
Price Target: $3.75$2.75
Current: $8.78
Upside: -68.68%
Maintains: Neutral
Price Target: $250$260
Current: $228.61
Upside: +13.73%
Maintains: Buy
Price Target: $8$6
Current: $5.75
Upside: +4.35%
Upgrades: Neutral
Price Target: $28$32
Current: $13.36
Upside: +139.52%